EDITORIAL
Published on 17 Oct 2024
Editorial: Immunotherapy in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)
doi 10.3389/fimmu.2024.1501760
- 374 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immunotherapy in Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL)
Immunotherapy in Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL)
5,385
Total downloads
15k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
CASE REPORT
Published on 25 Sep 2024
Case report: sub-clinical extramedullary B-ALL in the setting of relapse following targeted therapy
doi 10.3389/fimmu.2024.1423487
- 914 views
ORIGINAL RESEARCH
Published on 12 Sep 2024
A CD8+ T cell related immune score predicts survival and refines the risk assessment in acute myeloid leukemia
doi 10.3389/fimmu.2024.1408109
- 772 views
ORIGINAL RESEARCH
Published on 16 Aug 2024
Anti-PD-1 combined with hypomethylating agent and CAG regimen bridging to allogeneic hematopoietic stem cell transplantation: a novel strategy for relapsed/refractory acute myeloid leukemia
doi 10.3389/fimmu.2024.1409302
- 1,076 views
ORIGINAL RESEARCH
Published on 20 Jun 2024
NAD metabolism-related genes provide prognostic value and potential therapeutic insights for acute myeloid leukemia
doi 10.3389/fimmu.2024.1417398
- 1,198 views
BRIEF RESEARCH REPORT
Published on 15 May 2024
Ex vivo characterization of acute myeloid leukemia patients undergoing hypomethylating agents and venetoclax regimen reveals a venetoclax-specific effect on non-suppressive regulatory T cells and bona fide PD-1+TIM3+ exhausted CD8+ T cells
doi 10.3389/fimmu.2024.1386517
- 1,283 views
CASE REPORT
Published on 28 Feb 2024
Case report: Two pediatric cases of long-term leukemia-free survival with relapsed acute T-lymphoblastic leukemia treated with donor CD7 CAR-T cells bridging to haploidentical stem cell transplantation
doi 10.3389/fimmu.2024.1333037
- 1,328 views
ORIGINAL RESEARCH
Published on 23 Feb 2024
Key candidate genes and pathways in T lymphoblastic leukemia/lymphoma identified by bioinformatics and serological analyses
doi 10.3389/fimmu.2024.1341255
- 2,499 views
- 1 citation
REVIEW
Published on 17 Jan 2024
Contribution of the TIME in BCP-ALL: the basis for novel approaches therapeutics
doi 10.3389/fimmu.2023.1325255
- 1,739 views
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 15kTopic views
- 9,841Article views
- 5,385Article downloads